Detalhe da pesquisa
1.
The novel selective PDE9 inhibitor BAY 73-6691 improves learning and memory in rodents.
Neuropharmacology
; 55(5): 908-18, 2008 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-18674549
2.
Inhibition of phosphodiesterase 2 increases neuronal cGMP, synaptic plasticity and memory performance.
Neuropharmacology
; 47(7): 1081-92, 2004 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-15555642
3.
Pharmacological and behavioral profile of N-[(3R)-1-azabicyclo[2.2.2]oct-3-yl]-6-chinolincarboxamide (EVP-5141), a novel α7 nicotinic acetylcholine receptor agonist/serotonin 5-HT3 receptor antagonist.
Psychopharmacology (Berl)
; 227(1): 1-17, 2013 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-23241647
4.
Effects of the cognition impairer MK-801 on learning and memory in mice and rats.
Behav Brain Res
; 220(1): 215-29, 2011 Jun 20.
Artigo
em Inglês
| MEDLINE | ID: mdl-21310186
5.
The novel alpha7 nicotinic acetylcholine receptor agonist N-[(3R)-1-azabicyclo[2.2.2]oct-3-yl]-7-[2-(methoxy)phenyl]-1-benzofuran-2-carboxamide improves working and recognition memory in rodents.
J Pharmacol Exp Ther
; 321(2): 716-25, 2007 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-17308038
6.
Characterization of the first potent and selective PDE9 inhibitor using a cGMP reporter cell line.
Mol Pharmacol
; 68(6): 1775-81, 2005 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-16150925
7.
Alternative splicing and neuritic mRNA translocation under long-term neuronal hypersensitivity.
Science
; 295(5554): 508-12, 2002 Jan 18.
Artigo
em Inglês
| MEDLINE | ID: mdl-11799248